Jiangsu Bioperfectus Technologies Past Earnings Performance
Past criteria checks 0/6
Jiangsu Bioperfectus Technologies's earnings have been declining at an average annual rate of -4.5%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 12.7% per year.
Key information
-4.5%
Earnings growth rate
-5.3%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 12.7% |
| Return on equity | -8.0% |
| Net Margin | -70.1% |
| Next Earnings Update | 26 Oct 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Jiangsu Bioperfectus Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 394 | -276 | 350 | 113 |
| 31 Mar 24 | 400 | -314 | 386 | 121 |
| 31 Dec 23 | 403 | -374 | 407 | 135 |
| 30 Sep 23 | 1,518 | 28 | 513 | 116 |
| 30 Jun 23 | 2,455 | 526 | 493 | 149 |
| 31 Mar 23 | 4,107 | 1,177 | 629 | 192 |
| 31 Dec 22 | 5,535 | 1,828 | 779 | 185 |
| 30 Sep 22 | 4,961 | 1,821 | 705 | 213 |
| 30 Jun 22 | 4,974 | 1,925 | 738 | 176 |
| 31 Mar 22 | 3,504 | 1,437 | 592 | 117 |
| 31 Dec 21 | 2,839 | 1,193 | 547 | 106 |
| 30 Sep 21 | 2,811 | 1,234 | 536 | 89 |
| 30 Jun 21 | 2,298 | 1,014 | 490 | 81 |
| 31 Mar 21 | 2,396 | 1,103 | 486 | 75 |
| 31 Dec 20 | 1,740 | 820 | 373 | 70 |
| 30 Sep 20 | 1,199 | 616 | 229 | 56 |
| 30 Jun 20 | 739 | 361 | 176 | 47 |
| 31 Mar 20 | 436 | 174 | 145 | 42 |
| 31 Dec 19 | 289 | 84 | 114 | 37 |
| 30 Sep 19 | 263 | 74 | 184 | 50 |
| 31 Dec 18 | 231 | 64 | 103 | 26 |
| 31 Dec 17 | 187 | 43 | 93 | 21 |
| 31 Dec 16 | 129 | 8 | 86 | 14 |
Quality Earnings: 688399 is currently unprofitable.
Growing Profit Margin: 688399 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 688399 is unprofitable, and losses have increased over the past 5 years at a rate of 4.5% per year.
Accelerating Growth: Unable to compare 688399's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 688399 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.6%).
Return on Equity
High ROE: 688399 has a negative Return on Equity (-8.04%), as it is currently unprofitable.